Ecstasy-for-Medicine Advocate Raises $100 Million
Updated Jan. 5, 2024 8:54 am ETThe Multidisciplinary Association for Psychedelic Studies, a nonprofit leader in the pharmaceutical psychedelics industry, ...
Updated Jan. 5, 2024 8:54 am ETThe Multidisciplinary Association for Psychedelic Studies, a nonprofit leader in the pharmaceutical psychedelics industry, ...
Dec. 16, 2023 10:00 am ETA mass recall of Tesla’s Autopilot feature and crisis at General Motors’ autonomous-taxi business might ...
It usually takes time for scientific discoveries in the lab to make their way to the market.The groundbreaking gene-editing technology ...
Updated Nov. 1, 2023 8:15 am ETSingapore’s top financial regulator has lost patience with the city-state’s largest bank after repeated ...
Wood is still bullish on Twitter’s long-term outlook and said her fund updates its internal valuations of private companies frequently.
The potential FDA approval of BioMarin’s gene therapy for hemophilia A would be a major win, but patient uptake could ...
Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients.
ShareListen(2 min)
MarketsU.S. MarketsHere are seven major companies whose stocks moved on the week’s news
MarketsU.S. MarketsOil prices sink as sanctions hit Russian energy; bond yields climb